BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17386079)

  • 1. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
    Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
    Front Immunol; 2019; 10():390. PubMed ID: 30899264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells.
    Aguilar OA; Gonzalez-Hinojosa MDR; Arakawa-Hoyt JS; Millan AJ; Gotthardt D; Nabekura T; Lanier LL
    J Leukoc Biol; 2023 Jan; 113(1):27-40. PubMed ID: 36822164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.
    White AL; Chan HT; French RR; Beers SA; Cragg MS; Johnson PW; Glennie MJ
    Cancer Immunol Immunother; 2013 May; 62(5):941-8. PubMed ID: 23543215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
    Simpson AP; Roghanian A; Oldham RJ; Chan HTC; Penfold CA; Kim HJ; Inzhelevskaya T; Mockridge CI; Cox KL; Bogdanov YD; James S; Tutt AL; Rycroft D; Morley P; Dahal LN; Teige I; Frendeus B; Beers SA; Cragg MS
    Cell Rep; 2022 Jul; 40(3):111099. PubMed ID: 35858562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.
    Stopforth RJ; Oldham RJ; Tutt AL; Duriez P; Chan HTC; Binkowski BF; Zimprich C; Li D; Hargreaves PG; Cong M; Reddy V; Leandro MJ; Cambridge G; Lux A; Nimmerjahn F; Cragg MS
    J Immunol; 2018 Mar; 200(5):1937-1950. PubMed ID: 29351998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the TGN1412 anti-CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super-agonist activity.
    Chenoweth AM; Esparon S; Wines BD; Schuurman J; Labrijn AF; Hogarth PM
    Immunol Cell Biol; 2023 Aug; 101(7):657-662. PubMed ID: 36997299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.
    Tsuboi N; Asano K; Lauterbach M; Mayadas TN
    Immunity; 2008 Jun; 28(6):833-46. PubMed ID: 18538590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity.
    Bournazos S; Hart SP; Chamberlain LH; Glennie MJ; Dransfield I
    J Immunol; 2009 Jun; 182(12):8026-36. PubMed ID: 19494328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
    Tutt AL; James S; Laversin SA; Tipton TR; Ashton-Key M; French RR; Hussain K; Vaughan AT; Dou L; Earley A; Dahal LN; Lu C; Dunscombe M; Chan HT; Penfold CA; Kim JH; Potter EA; Mockridge CI; Roghanian A; Oldham RJ; Cox KL; Lim SH; Teige I; Frendéus B; Glennie MJ; Beers SA; Cragg MS
    J Immunol; 2015 Dec; 195(11):5503-16. PubMed ID: 26512139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B).
    Roghanian A; Stopforth RJ; Dahal LN; Cragg MS
    J Leukoc Biol; 2018 Feb; ():. PubMed ID: 29406570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab.
    Leitner J; Egerer R; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Steinberger P
    Front Immunol; 2023; 14():1208631. PubMed ID: 37575254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.
    Dahal LN; Dou L; Hussain K; Liu R; Earley A; Cox KL; Murinello S; Tracy I; Forconi F; Steele AJ; Duriez PJ; Gomez-Nicola D; Teeling JL; Glennie MJ; Cragg MS; Beers SA
    Cancer Res; 2017 Jul; 77(13):3619-3631. PubMed ID: 28512240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia.
    Knorr K; Rahman J; Erickson C; Wang E; Monetti M; Li Z; Ortiz-Pacheco J; Jones A; Lu SX; Stanley RF; Baez M; Fox N; Castro C; Marino AE; Jiang C; Penson A; Hogg SJ; Mi X; Nakajima H; Kunimoto H; Nishimura K; Inoue D; Greenbaum B; Knorr D; Ravetch J; Abdel-Wahab O
    Nat Cancer; 2023 Dec; 4(12):1675-1692. PubMed ID: 37872381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies.
    Casey E; Bournazos S; Mo G; Mondello P; Tan KS; Ravetch JV; Scheinberg DA
    Leukemia; 2018 Feb; 32(2):547-549. PubMed ID: 28924242
    [No Abstract]   [Full Text] [Related]  

  • 16. Analyzing Fcγ-Receptor Interactions on Monocytes with the Proximity Ligation Assay (PLA).
    Kara S; Nimmerjahn F
    Methods Mol Biol; 2024; 2713():377-388. PubMed ID: 37639137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.
    Veri MC; Burke S; Huang L; Li H; Gorlatov S; Tuaillon N; Rainey GJ; Ciccarone V; Zhang T; Shah K; Jin L; Ning L; Minor T; Moore PA; Koenig S; Johnson S; Bonvini E
    Arthritis Rheum; 2010 Jul; 62(7):1933-43. PubMed ID: 20506263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I and type II Fc receptors regulate innate and adaptive immunity.
    Pincetic A; Bournazos S; DiLillo DJ; Maamary J; Wang TT; Dahan R; Fiebiger BM; Ravetch JV
    Nat Immunol; 2014 Aug; 15(8):707-16. PubMed ID: 25045879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII.
    Shahani T; Covens K; Lavend'homme R; Jazouli N; Sokal E; Peerlinck K; Jacquemin M
    J Thromb Haemost; 2014 Jan; 12(1):36-42. PubMed ID: 24118899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of neonatal Fc receptor in the eye.
    Powner MB; McKenzie JA; Christianson GJ; Roopenian DC; Fruttiger M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1607-15. PubMed ID: 24550358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.